{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:18:43Z","timestamp":1778689123022,"version":"3.51.4"},"reference-count":89,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["11423"],"award-info":[{"award-number":["11423"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marie Curie International Reintegration Grant","award":["PIRG08-GA-2010-277008"],"award-info":[{"award-number":["PIRG08-GA-2010-277008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Trabectedin (ET743) and lurbinectedin (PM01183) limit the production of inflammatory cytokines that are elevated during cancer cachexia. Mice carrying C26 colon adenocarcinoma display cachexia (i.e., premature death and body wasting with muscle, fat and cardiac tissue depletion), high levels of inflammatory cytokines and subsequent splenomegaly. We tested whether such drugs protected these mice from cachexia. Ten-week-old mice were inoculated with C26 cells and three days later randomized to receive intravenously vehicle or 0.05 mg\/kg ET743 or 0.07 mg\/kg PM01183, three times a week for three weeks. ET743 or PM01183 extended the lifespan of C26-mice by 30% or 85%, respectively, without affecting tumor growth or food intake. Within 13 days from C26 implant, both drugs did not protect fat, muscle and heart from cachexia. Since PM01183 extended the animal survival more than ET743, we analyzed PM01183 further. In tibialis anterior of C26-mice, but not in atrophying myotubes, PM01183 restrained the NF-\u03baB\/PAX7\/myogenin axis, possibly reducing the pro-inflammatory milieu, and failed to limit the C\/EBP\u03b2\/atrogin-1 axis. Inflammation-mediated splenomegaly of C26-mice was inhibited by PM01183 for as long as the treatment lasted, without reducing IL-6, M-CSF or IL-1\u03b2 in plasma. ET743 and PM01183 extend the survival of C26-bearing mice unchanging tumor growth or cachexia but possibly restrain muscle-related inflammation and C26-induced splenomegaly.<\/jats:p>","DOI":"10.3390\/cancers12082312","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T06:33:20Z","timestamp":1597646000000},"page":"2312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3936-8895","authenticated-orcid":false,"given":"Giorgio","family":"Aquila","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-9108","authenticated-orcid":false,"given":"Andrea David","family":"Re Cecconi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Forti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Frapolli","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezia","family":"Bello","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Novelli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-3798","authenticated-orcid":false,"given":"Ilaria","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta Andrea","family":"Licandro","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Staszewsky","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Benedetta","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Talamini","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pasetto","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Resovi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Giavazzi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Scanziani","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Veterinaria, Universit\u00e0 di Milano, 20133 Milan, Italy"},{"name":"Mouse and Animal Pathology Lab (MAPLab), Fondazione UniMi, Universit\u00e0 di Milano, 20139 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-5186","authenticated-orcid":false,"given":"Giorgia","family":"Careccia","sequence":"additional","affiliation":[{"name":"Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"V\u00e9n\u00e9reau","sequence":"additional","affiliation":[{"name":"Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"D'Incalci","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-9352","authenticated-orcid":false,"given":"Rosanna","family":"Piccirillo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS, 20156 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1096\/fj.12-222844","article-title":"Diaphragm and ventilatory dysfunction during cancer cachexia","volume":"27","author":"Roberts","year":"2013","journal-title":"FASEB J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.2930130205","article-title":"An investigation of the cause of death from cancer","volume":"13","author":"Houten","year":"1980","journal-title":"J. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: Molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/0008-5472.CAN-13-1052","article-title":"Cancer usurps skeletal muscle as an energy repository","volume":"74","author":"Luo","year":"2014","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Miller, J., Laird, B.J.A., and Skipworth, R.J.E. (2019). The immunological regulation of cancer cachexia and its therapeutic implications. J. Cancer Metastasis Treat., 2019.","DOI":"10.20517\/2394-4722.2019.001"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/379739a0","article-title":"Characterization of a cancer cachectic factor","volume":"379","author":"Todorov","year":"1996","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/15384101.2015.1010979","article-title":"Inactivating STAT3: Bad for tumor, good for muscle","volume":"14","author":"Piccirillo","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Marchildon, F., Lamarche, \u00c9., Lala-Tabbert, N., St-Louis, C., and Wiper-Bergeron, N. (2015). Expression of CCAAT\/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145583"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1038\/cddis.2016.4","article-title":"CCAAT\/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia","volume":"7","author":"Marchildon","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"C101","DOI":"10.1152\/ajpcell.00344.2015","article-title":"Valproic acid attenuates skeletal muscle wasting by inhibiting C\/EBP\u03b2-regulated atrogin1 expression in cancer cachexia","volume":"311","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s12325-016-0344-3","article-title":"Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives","volume":"33","author":"Gordon","year":"2016","journal-title":"Adv. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1200\/JCO.2019.37.15_suppl.8506","article-title":"Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial","volume":"37","author":"Besse","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jimenez, P.C., Wilke, D.V., Branco, P.C., Bauermeister, A., Rezende-Teixeira, P., Gaud\u00eancio, S.P., and Costa-Lotufo, L.V. (2019). Enriching Cancer Pharmacology with Drugs of Marine Origin. Br. J. Pharmacol.","DOI":"10.1111\/bph.14876"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2017.205","article-title":"Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models","volume":"117","author":"Belgiovine","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/ijc.28213","article-title":"Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis\u00ae (PM00104)","volume":"133","author":"Romano","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1158\/1078-0432.CCR-13-1880","article-title":"First-in-human phase I study of Lurbinectedin (PM01183) in patients with advanced solid tumors","volume":"20","author":"Elez","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Busquets","year":"2019","journal-title":"Nutrition"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1158\/0008-5472.CAN-09-2335","article-title":"Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells","volume":"70","author":"Germano","year":"2010","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1200\/jco.2012.30.15_suppl.10047","article-title":"Association between body weight and efficacy outcomes during trabectedin therapy for recurrent advanced soft tissue sarcoma (STS)","volume":"30","author":"Galmarini","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/cam4.1130","article-title":"Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma","volume":"6","author":"Nakai","year":"2017","journal-title":"Cancer Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/onc.2016.153","article-title":"Activation of the SDF1\/CXCR4 pathway retards muscle atrophy during cancer cachexia","volume":"35","author":"Martinelli","year":"2016","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bonetto, A., Rupert, J.E., Barreto, R., and Zimmers, T.A. (2016). The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia. J. Vis. Exp.","DOI":"10.3791\/54893"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Aulino, P., Berardi, E., Cardillo, V.M., Rizzuto, E., Perniconi, B., Ramina, C., Padula, F., Spugnini, E.P., Baldi, A., and Faiola, F. (2010). Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-363"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"41146","DOI":"10.18632\/oncotarget.5843","article-title":"Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth","volume":"6","author":"Shukla","year":"2015","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_33","first-page":"347","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"37","author":"Tian","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Re Cecconi, A.D., Forti, M., Chiappa, M., Zhu, Z., Zingman, L.V., Cervo, L., Beltrame, L., Marchini, S., and Piccirillo, R. (2019). Musclin, a Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice. Cancers, 11.","DOI":"10.3390\/cancers11101541"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.12.019","article-title":"Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice","volume":"91","author":"Assi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2010.09.004","article-title":"Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases","volume":"143","author":"Moresi","year":"2010","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jcsm.12539","article-title":"Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice","volume":"11","author":"Costamagna","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D.C., Khuri, S., Koniaris, L.G., and Zimmers, T.A. (2011). STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022538"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphys.2017.00738","article-title":"Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture","volume":"8","author":"Jackman","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13765-019-0417-5","article-title":"Potential role of immunological factors in early diagnosis of cancer cachexia in C26 tumor-bearing mice","volume":"62","author":"Ju","year":"2019","journal-title":"Appl. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.mco.0000134363.53782.cb","article-title":"Cancer anorexia-cachexia syndrome: Cytokines and neuropeptides","volume":"7","author":"Ramos","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: Therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12104","article-title":"Expression of Concern: HMGB 1 mediates splenomegaly and expansion of splenic CD 11b+ L y-6Chigh inflammatory monocytes in murine sepsis survivors","volume":"274","author":"Olofsson","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_47","first-page":"193","article-title":"Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice","volume":"17","author":"DiGiovanna","year":"1991","journal-title":"Blood Cells"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3816\/CCC.2007.n.018","article-title":"Phase II study of trabectedin in pretreated patients with advanced colorectal cancer","volume":"6","author":"Casado","year":"2007","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","article-title":"Muscle type and fiber type specificity in muscle wasting","volume":"45","author":"Ciciliot","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"H1154","DOI":"10.1152\/ajpheart.00090.2016","article-title":"Increased hypoxia-inducible factor-1\u03b1 in striated muscle of tumor-bearing mice","volume":"312","author":"Devine","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","article-title":"Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner","volume":"71","author":"Cosper","year":"2011","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"H685","DOI":"10.1152\/ajpheart.00106.2015","article-title":"Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia","volume":"309","author":"Devine","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0735-1097(03)00421-2","article-title":"Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes","volume":"41","author":"Ammann","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jcsm.12204","article-title":"Cardiac troponin T and fast skeletal muscle denervation in ageing","volume":"8","author":"Xu","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jcsm.12451","article-title":"Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung","volume":"10","author":"Becher","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/jcmm.12342","article-title":"TNF-\u03b1-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs","volume":"18","author":"Chen","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0092-8674(00)00066-0","article-title":"Pax7 is required for the specification of myogenic satellite cells","volume":"102","author":"Seale","year":"2000","journal-title":"Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6729268","DOI":"10.1155\/2016\/6729268","article-title":"Spontaneous Physical Activity Downregulates Pax7 in Cancer Cachexia","volume":"2016","author":"Coletti","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1096\/fj.14-249748","article-title":"A satellite cell-specific knockout of the androgen receptor reveals myostatin as a direct androgen target in skeletal muscle","volume":"28","author":"Dubois","year":"2014","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4103\/1008-682X.122861","article-title":"Expression of androgen receptor target genes in skeletal muscle","volume":"16","author":"Rana","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Penna, F., Costamagna, D., Fanzani, A., Bonelli, G., Baccino, F.M., and Costelli, P. (2010). Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013604"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.18632\/aging.101724","article-title":"Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia","volume":"10","author":"Levolger","year":"2018","journal-title":"Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3945\/ajcn.113.058388","article-title":"Nuclear transcription factor \u03ba B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia","volume":"98","author":"Langen","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1038\/s41388-018-0394-x","article-title":"HMGA1\/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance","volume":"37","author":"Loria","year":"2018","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wysong, A., Asher, S.A., Yin, X.R., Gore, M., and Weinstein, L. (2011). Selective Inhibition of NF-kappa-B with NBD Peptide Reduces Tumor-Induced Wasting in a Murine Model of Cancer Cachexia In vivo. J. Cancer Sci. Ther., 3.","DOI":"10.4172\/1948-5956.1000052"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-04-4037","article-title":"Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): Inhibition of macrophage differentiation and cytokine production","volume":"65","author":"Allavena","year":"2005","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","article-title":"Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors","volume":"82","author":"Hunter","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"ref_72","first-page":"2267","article-title":"Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines","volume":"41","author":"Sato","year":"1981","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.181.7.4676","article-title":"A novel role for CD4+ T cells in the control of cachexia","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0148607108325075","article-title":"Myeloid-derived suppressor cells in cancer cachexia syndrome: A new explanation for an old problem","volume":"32","author":"Winfield","year":"2008","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel Role for Tumor-Induced Expansion of Myeloid-Derived Cells in Cancer Cachexia","volume":"192","author":"Cuenca","year":"2014","journal-title":"J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01516994","article-title":"Splenectomy before tumor inoculation prolongs the survival time of cachectic mice","volume":"41","author":"Soda","year":"1995","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jso.2930220202","article-title":"Effect of splenectomy on the growth of murine colon tumors","volume":"22","author":"Sato","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2217\/imt-2017-0046","article-title":"PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo","volume":"9","author":"Kuroda","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00280-015-2918-1","article-title":"Unique features of trabectedin mechanism of action","volume":"77","author":"Larsen","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_80","unstructured":"Bizzarri, M. (2020). Trabectedin, a Drug Acting on Both Cancer Cells and the Tumor Microenvironment. Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine, Springer International Publishing."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mesa, R.A., and Passamonti, F. (2016). Individualizing Care for Patients with Myeloproliferative Neoplasms: Integrating Genetics, Evolving Therapies, and Patient-Specific Disease Burden. Am. Soc. Clin. Oncol. Educ. Book, e324\u2013e335.","DOI":"10.14694\/EDBK_159322"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jcsm.12310","article-title":"Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses: Treating cachexia using soluble ACVR2B","volume":"9","author":"Nissinen","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0165-4608(02)00623-4","article-title":"Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines","volume":"139","author":"Wiegant","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/09540105.2018.1516739","article-title":"Ferulic acid suppresses obesity and obesity-related metabolic syndromes in high fat diet-induced obese C57BL\/6J mice","volume":"29","author":"Wang","year":"2018","journal-title":"Food Agric. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/en.2017-00168","article-title":"Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice","volume":"158","author":"Mosa","year":"2017","journal-title":"Endocrinology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1158\/0008-5472.CAN-11-1919","article-title":"Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts","volume":"72","author":"Moschetta","year":"2012","journal-title":"Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201503-0620OC","article-title":"Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort","volume":"192","author":"Goligher","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1038\/s41598-019-40393-0","article-title":"A novel echocardiographic method closely agrees with cardiac magnetic resonance in the assessment of left ventricular function in infarcted mice","volume":"9","author":"Russo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.medengphy.2008.03.006","article-title":"In vivo quantification of subcutaneous and visceral adiposity by micro-computed tomography in a small animal model","volume":"31","author":"Luu","year":"2009","journal-title":"Med. Eng. Phys."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/8\/2312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:01:59Z","timestamp":1760176919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/8\/2312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":89,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["cancers12082312"],"URL":"https:\/\/doi.org\/10.3390\/cancers12082312","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}